首页> 外文期刊>American Journal of Infectious Diseases and Microbiology >Transfusion Transmissible Viral Infections Risk at Two Teaching Hospitals Blood Banks in Nigeria
【24h】

Transfusion Transmissible Viral Infections Risk at Two Teaching Hospitals Blood Banks in Nigeria

机译:尼日利亚两家教学医院血库中的输血传播性病毒感染风险

获取原文
           

摘要

Background/ Objectives: Transfusion Transmissible viral infections such as HIV, HBV and HCV are infectious agents that can pose a threat to blood safety. The aim of this study is to determine the prevalence and coinfection of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) among blood donors tested negative to these viruses by rapid test devices. Materials and Methods: Two hundred and twelve (212) healthy blood donors (108 and 104 from UATH and NAUTH respectively) certified fit for blood donation were recruited for this study. One hundred and nine eighty (198) samples that were seronegative for HBsAg, HIV, HCV and Syphilis by rapid test were examined for the presence of HBsAg, Anti-HCV and HIV (Ab + Ag) using 4TH generation ELISA. Qualitative conventional PCR was used to confirm ELISA positive sera for HBV DNA, HIV RNA and HCV RNA. Results: Out of 198 blood donor samples negative for HBV, HCV and HIV by rapid test, 13.7%, 13.7% and 8.1% were positive by ELISA for HBV, HIV and HCV respectively. Twelve samples (6.1%) have coinfection of TTIs. One (1) sample out of the 12 samples is co-infected with these three viral (HBV, HCV and HIV) agents. Of the 28 samples positive for HBV by ELISA, 20 (71.4%) were positive for HBV DNA, 8 (36.4%) of 22 positive samples by HIV ELISA were positive for HIV RNA and 4 (28.6%) of 14 samples were positive for HCV RNA (p=0.0001). Conclusion and Recommendations: There is a high prevalence of transfusion transmissible viral infections among blood donors at our study population. This study therefore recommends blood donors in these Hospitals in particular and Nigeria in general be screened for HIV, HCV and HBsAg using ELISA 4th generation test kits and Nucleic Acid Testing (NAT).
机译:背景/目标:输血诸如HIV,HBV和HCV等可传播的病毒感染是可以威胁血液安全的传染原。这项研究的目的是确定通过快速检测设备对这些病毒呈阴性反应的献血者中乙型肝炎病毒(HBV),丙型肝炎病毒(HCV)和人类免疫缺陷病毒(HIV)的患病率和合并感染率。材料和方法:招募了经认证适合献血的一百二十二(212)名健康献血者(分别来自UATH和NAUTH的108位和104位)用于这项研究。通过快速检测,使用第四代ELISA检测了190例(198)对HBsAg,HIV,HCV和梅毒呈阴性的样本,检查是否存在HBsAg,抗HCV和HIV(Ab + Ag)。使用定性常规PCR确认HBV DNA,HIV RNA和HCV RNA的ELISA阳性血清。结果:在快速检测的198份HBV,HCV和HIV阴性献血者样本中,ELISA检测HBV,HIV和HCV阳性分别为13.7%,13.7%和8.1%。十二个样本(6.1%)合并感染了TTI。在这12个样本中,一(1)个样本与这三种病毒(HBV,HCV和HIV)药物共同感染。在ELISA呈阳性的28个样本中,HBV DNA呈阳性20个(占71.4%),HIV ELISA呈阳性的22个样本中有8个(占36.4%)HIV RNA阳性,14个样本中有4个(占28.6%)呈阳性。 HCV RNA(p = 0.0001)。结论和建议:在我们的研究人群中,献血者中输血传播性病毒感染的发生率很高。因此,这项研究建议使用ELISA第四代检测试剂盒和核酸检测(NAT)对这些医院尤其是尼日利亚的献血者进行HIV,HCV和HBsAg筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号